Positioned to Grow the Psychedelics Market
NeonMind has two business divisions focused on complementary aspects of the psychedelics market: a pharmaceutical division developing psilocybin-based drug candidates targeting obesity and weight management, and a medical services division which will be launching specialty mental health clinics in Canada that incorporate innovative, evidence-backed validated interventional psychiatry treatments for mood and anxiety disorders.